Durvalumab With Chemotherapy Followed by Sequential Radiotherapy for Limited Stage Small Cell Lung Cancer
Clinical trial NCT05034133 · UNKNOWN
Trial details
- NCT number
- NCT05034133
- Sponsor
- Beijing Haidian Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2023-08-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.